Jubilant Pharmova Limited
Credit Rating
01 / The disclosure
What the company shared
Jubilant Pharmova Limited has informed the Exchange about Credit Rating
A question for your research
Check the authority, amount, company response and appeal status. A notice and a final liability are different stages.
The evidence
Read the source excerpts
01Sub.: Disclosure under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 – Credit rating assigned by ICRA Limited to proposed Non-Convertible Debentures
Page 1
02Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that ICRA Limited has assigned the following credit rating to the Company’s proposed non - convertible debentures:
Page 1
03Instrument Amount (₹ crore) Rating Action Proposed Non-Convertible Debentures 1,400.00 [ICRA]AA+ (Stable) — Assigned
Page 1
04The aforesaid rating has been assigned vide ICRA Limited’s letter bearing reference no.
Page 1
05Date and time of receipt of the rating communication: October 13, 2026, at 5:09 p.m.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106817345
- First collected
- 14 Oct 2026, 16:46 IST
- PDF extraction
- extracted · 1 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- c8edc80db035a17cd5010264b8d79afe4028aa090e8bf10131bcca60ab032b9f